In focus · trending topic

VYGR

27 stories · following the connections

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC

Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease

By Nasdaq OMXJun 1, 2017, 11:27 AM UTC